TSC
Two Seas Capital Portfolio holdings
AUM
$1.02B
This Quarter Return
+9.18%
1 Year Return
+18.32%
3 Year Return
+191.51%
5 Year Return
–
10 Year Return
–
AUM
$613M
AUM Growth
+$613M
(+20%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
23.55%
Top 10 Holdings %
Top 10 Hldgs %
91.11%
Holding
21
New
2
Increased
10
Reduced
4
Closed
1
Top Buys
| 1 |
TLN
Talen Energy Corporation Common Stock
TLN
|
$51.7M |
| 2 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$25.3M |
| 3 |
Roivant Sciences
ROIV
|
$25.2M |
| 4 |
Core Scientific
CORZ
|
$22.4M |
| 5 |
Vistra
VST
|
$10M |
Top Sells
| 1 |
Indivior
INDV
|
$10M |
| 2 |
Meta Platforms (Facebook)
META
|
$504K |
| 3 |
Tourmaline Bio
TRML
|
$501K |
| 4 |
Arcutis Biotherapeutics
ARQT
|
$438K |
| 5 |
Odyssey Marine Exploration
OMEX
|
$424K |
Sector Composition
| 1 | Healthcare | 67.09% |
| 2 | Utilities | 12.84% |
| 3 | Technology | 11.16% |
| 4 | Communication Services | 4.01% |
| 5 | Materials | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Indivior
INDV
$3.03B
| $204M | 33.09% | 12,630,026 -620,976 | -5% | -$10M |
|
|
2
Roivant Sciences
ROIV
$8.15B
| $109M | 17.73% | 10,318,764 +2,388,415 | +30% | +$25.2M |
|
|
3
Core Scientific
CORZ
$4.38B
| $58M | 9.43% | 6,239,591 +2,408,624 | +63% | +$22.4M |
|
|
TLN
4
Talen Energy Corporation Common Stock
TLN
$17.3B
| $51.7M | 8.4% | +465,683 | New | +$51.7M |
|
|
AVDL
5
Avadel Pharmaceuticals
AVDL
$1.43B
| $29.7M | 4.83% | 2,115,279 +1,797,039 | +565% | +$25.3M |
|
|
6
Vistra
VST
$64.1B
| $27M | 4.39% | 314,082 +116,729 | +59% | +$10M |
|
7
Arbutus Biopharma
ABUS
$711M
| $26.5M | 4.3% | 8,571,751 +729,824 | +9% | +$2.26M |
|
8
Immunovant
IMVT
$2.56B
| $18.3M | 2.97% | 692,406 +151,111 | +28% | +$3.99M |
|
|
9
Meta Platforms (Facebook)
META
$1.86T
| $15.6M | 2.54% | 30,958 -1,000 | -3% | -$504K |
|
10
Esperion Therapeutics
ESPR
$448M
| $12.7M | 2.07% | 5,735,660 +1,570,003 | +38% | +$3.49M |
|
11
Sonos
SONO
$1.68B
| $10.4M | 1.69% | 703,928 +300,275 | +74% | +$4.43M |
|
12
Alphabet (Google) Class A
GOOGL
$2.57T
| $8.99M | 1.46% | 49,371 +25,000 | +103% | +$4.55M |
|
|
13
Arcutis Biotherapeutics
ARQT
$1.86B
| $7.09M | 1.15% | 762,190 -47,142 | -6% | -$438K |
|
|
14
Odyssey Marine Exploration
OMEX
$88.6M
| $5.62M | 0.91% | 1,150,666 -86,949 | -7% | -$424K |
|
15
Sotera Health
SHC
$4.65B
| $4.15M | 0.68% | 350,000 +50,000 | +17% | +$594K |
|
16
TeraWulf
WULF
$3.71B
| $2.23M | 0.36% | +500,000 | New | +$2.23M |
|
|
17
Core Scientific, Inc. Tranche 2 Warrants
CORZZ
$1.17B
| $2.02M | 0.33% | 233,540 | – | – |
|
|
18
Core Scientific, Inc. Tranche 1 Warrants
CORZW
$812M
| $1.26M | 0.21% | 280,248 | – | – |
|
19
Exelixis
EXEL
$10.1B
| – | – | 0 | – | – |
|
|
20
Tourmaline Bio
TRML
$601M
| – | – | -21,891 | Closed | -$501K |
|